Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors

Clinical trial NCT04716634 · COMPLETED

Trial details

NCT number: NCT04716634
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2021-04-19
Primary completion: 2024-02-22
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.